Botanix Pharmaceuticals Limited (AU:BOT) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Botanix Pharmaceuticals Limited has issued over 3.4 million new shares, which are now available for immediate trading, following the exercise of equivalent unquoted options. The company, a pioneer in dermatological treatments, recently received FDA approval for Sofdra™, a novel product for primary axillary hyperhidrosis, and is advancing a pipeline of late-stage clinical products for various skin conditions.
For further insights into AU:BOT stock, check out TipRanks’ Stock Analysis page.